SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-119512
Filing Date
2016-05-10
Accepted
2016-05-10 08:31:55
Documents
52
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a16-6596_110q.htm 10-Q 658677
2 EX-10.1 a16-6596_1ex10d1.htm EX-10.1 49125
3 EX-31.1 a16-6596_1ex31d1.htm EX-31.1 10501
4 EX-31.2 a16-6596_1ex31d2.htm EX-31.2 10953
5 EX-32.1 a16-6596_1ex32d1.htm EX-32.1 8259
  Complete submission text file 0001104659-16-119512.txt   3509235

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snta-20160331.xml EX-101.INS 684569
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snta-20160331.xsd EX-101.SCH 32097
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT snta-20160331_cal.xml EX-101.CAL 31302
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT snta-20160331_lab.xml EX-101.LAB 320188
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snta-20160331_pre.xml EX-101.PRE 224800
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT snta-20160331_def.xml EX-101.DEF 121615
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 161633814
SIC: 2834 Pharmaceutical Preparations